A community for China's biotech and pharmaceutical industries.

The biotech and pharmaceutical industries are taking priority in China. Recent changes to safety regulations and a general reorganization have increased BioChina’s productivity and influence in the life sciences. With a large scientific community, BioChina has appealed to foreign biotech companies, which now have a strong presence within the country and in the global market. China’s strong economy and dedication to the life sciences is expected to contribute to a thriving biotech industry now and in the future.

Sponsor
Pfizer


Hotbed News
Chinese Firm Sinocare Eyes Bayer (BAY)'s Diabetes Business Friday, May 22, 2015
BeiGene Co.,Ltd Nabs $97 Million Thursday, May 14, 2015
Parsing Biotech's B-Word: Why Growing Bubble Fear May Be Your Opportunity Thursday, April 30, 2015
Resverlogix Corporation (RVX.TO), Shenzhen Hepalink Pharma Strike Deal Worth $450 Million+ Monday, April 27, 2015
BioSpace (DHX) Temperature Poll: Will Mylan (MYL) Buy Teva (TEVA), As Predator Becomes Prey? Wednesday, May 20, 2015
First Experiment "Editing" Human Embryos Ignites Ethical Furor Monday, April 27, 2015
Guizhou Xinbang Pharma Buys Hangzhou Chinese Peptide For $323 Million Wednesday, May 06, 2015
BioSpace (DHX) Temperature Poll: Will AbbVie (ABBV), Genentech (RHHBY)’s New Cancer Drug Be a Game Changer? Friday, May 15, 2015
Macro-Union Pharma Accused Of Animal Abuse For Hanging Cat Carcasses Thursday, April 16, 2015
Shanghai Haohai Biological To Stage $305 Million IPO In Hong Kong Wednesday, April 22, 2015
12345678910